Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS
· Delayed Price · Currency is USD
0.332
+0.027 (8.92%)
Apr 27, 2023, 2:59 PM EST
Sorrento Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | -548 | -572.84 | -428.33 | -298.46 | -292.07 | -203.54 | Upgrade
|
| Depreciation & Amortization | 13.93 | 13.25 | 12.46 | 11.01 | 10.99 | 9.12 | Upgrade
|
| Other Amortization | 5.25 | - | - | - | - | 0.37 | Upgrade
|
| Asset Writedown & Restructuring Costs | 46.16 | 136.46 | 24.21 | 42.99 | 75.3 | 11.73 | Upgrade
|
| Loss (Gain) From Sale of Investments | 76.17 | 83.92 | 15.01 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 18.74 | 18.43 | 0.13 | 5.84 | 3.91 | 5.02 | Upgrade
|
| Stock-Based Compensation | 69.21 | 74.85 | 90.19 | 31.42 | 12.65 | 6.21 | Upgrade
|
| Other Operating Activities | -48.64 | -117.46 | 7.3 | 43.86 | 8.77 | 53.19 | Upgrade
|
| Change in Accounts Receivable | -11.55 | -5.68 | -2.96 | -1.05 | -10.62 | -1.62 | Upgrade
|
| Change in Inventory | 0.03 | -9.51 | -6.28 | 1.53 | - | - | Upgrade
|
| Change in Accounts Payable | 33.59 | 9.87 | -3.88 | -3.68 | 10.22 | 3.58 | Upgrade
|
| Change in Unearned Revenue | -110.35 | -112.3 | -1.02 | -0.36 | -0.95 | -3.26 | Upgrade
|
| Change in Other Net Operating Assets | 208.22 | 187.17 | 11.34 | 7.36 | 8.8 | 7.45 | Upgrade
|
| Operating Cash Flow | -234.63 | -293.86 | -281.82 | -159.54 | -173 | -111.77 | Upgrade
|
| Capital Expenditures | -8.59 | -13.66 | -8.87 | -6.53 | -11.44 | -21.2 | Upgrade
|
| Cash Acquisitions | 3.55 | -6.54 | -0.75 | - | -26.73 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -8.32 | -8.32 | -35.3 | -33.4 | - | - | Upgrade
|
| Investment in Securities | 1.77 | - | 124.77 | - | - | - | Upgrade
|
| Investing Cash Flow | -11.58 | -28.52 | 79.85 | -39.92 | -38.17 | -21.2 | Upgrade
|
| Short-Term Debt Issued | - | 96.07 | 49.74 | 18.59 | 8 | 21.26 | Upgrade
|
| Long-Term Debt Issued | - | 3.38 | - | - | 17.41 | 263.38 | Upgrade
|
| Total Debt Issued | 160.34 | 99.45 | 49.74 | 18.59 | 25.41 | 284.65 | Upgrade
|
| Long-Term Debt Repaid | - | -188.31 | -85.66 | -205.56 | -3.07 | -42.47 | Upgrade
|
| Net Debt Issued (Repaid) | 78.08 | -88.87 | -35.91 | -186.98 | 22.34 | 242.18 | Upgrade
|
| Issuance of Common Stock | 155.68 | 403.53 | 217.25 | 416.22 | 56.55 | 83.82 | Upgrade
|
| Other Financing Activities | 12.84 | -2.95 | - | -55 | - | - | Upgrade
|
| Financing Cash Flow | 246.59 | 311.72 | 181.33 | 174.24 | 78.89 | 326 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.97 | -2.37 | 0.84 | 0.92 | -0.28 | -0.14 | Upgrade
|
| Net Cash Flow | -0.6 | -13.03 | -19.8 | -24.31 | -132.56 | 192.9 | Upgrade
|
| Free Cash Flow | -243.21 | -307.51 | -290.69 | -166.06 | -184.44 | -132.96 | Upgrade
|
| Free Cash Flow Margin | -378.42% | -489.37% | -549.47% | -415.31% | -586.78% | -627.39% | Upgrade
|
| Free Cash Flow Per Share | -0.48 | -0.73 | -0.99 | -0.72 | -1.31 | -1.25 | Upgrade
|
| Cash Interest Paid | 3.17 | 1.17 | 1.06 | 3.42 | 12.74 | 1.62 | Upgrade
|
| Cash Income Tax Paid | 0.09 | 0.03 | 1.2 | - | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -57.53 | 25.73 | -167.98 | -126.73 | -131.79 | -161.63 | Upgrade
|
| Unlevered Free Cash Flow | -58.52 | 31.09 | -161.59 | -114.13 | -109.88 | -125.61 | Upgrade
|
| Change in Net Working Capital | -97.32 | -201.53 | -9.95 | -9.32 | 0.09 | 39.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.